首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1629828

全球整形外科市場 - 2024-2031

Global Plastic Surgery Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球整形外科市場規模達697億美元，預計2031年將達到1,587億美元，2024-2031年預測期間複合年成長率為11.1%。

整形外科是一門外科專業，涉及改善人的外觀以及重建因疾病、創傷或先天性疾病造成的臉部和身體組織缺陷。整形手術可以恢復和改善功能以及外觀。它可以涉及除中樞神經系統之外的任何解剖部位的手術。稱為整形外科的外科專業涉及人體的重建、增強或改變。整容手術和重建手術是整形手術的兩個子類別。

此外，由於老年人口的增加、微創手術的採用、手術成本的降低、市場上授權服務提供者數量的增加以及新產品推出數量的增加，消費者對這些整形手術的需求不斷成長。市場規模擴大。由於北美地區研究的發展，市場對北美地區產品的需求不斷成長。 Allergan Aesthetics (AbbVie Inc.)、Merz Aesthetics、Cynosure LLC 等重要競爭對手在市場上積極運作。

市場動態：

驅動程式和限制

整形手術的需求不斷增加

對整形外科手術的需求不斷成長預計將成為全球整形外科市場成長的重要因素。老年人口的增加、疤痕和受傷數量的增加、技術進步、最近的推出和批准等因素增加了對整形外科手術的需求。不斷成長的老年人口預計將對全球整形外科市場產生重大影響。隨著預期壽命的延長和老年人口的成長，越來越需要美容療程來解決與年齡相關的問題，例如皺紋、皮膚下垂和體積損失。作為改善外觀的一種方式，整容、真皮填充劑和肉毒桿菌注射在老年人中越來越受歡迎。

交通事故和燒傷發生率的上升導致越來越多的患者需要疤痕治療，增加了對疤痕修復和美容整形手術的需求。例如，根據世界衛生組織統計，每年估計有 18 萬人因燒傷而死亡。絕大多數發生在低收入和中等收入國家。在印度，每年有超過 100 萬人中度或重度燒傷。

由於美容和改善外觀的需要，進行的手術數量日益增加。例如，根據美國整形外科醫師協會的數據，2023年，美國總共進行了304,181例隆乳手術、347,782例抽脂手術以及120,747例眼瞼手術和手術。

老年人口的增加是預測期內市場成長的主要驅動力。隨著全球老年人口的增加，對整形手術的需求也增加。例如，根據聯合國預測，2023年，全球60歲以上人口將達10.6億，預計2030年同年齡層人口將增至13.3億。例如，2024年9月，艾伯維公司旗下的艾爾建美容公司宣布，肉毒桿菌（onabotulinumtoxinA）現已在中國上市，用於治療咬肌優勢症（MMP）。咬肌是下臉的咀嚼肌之一，它的優點可以導致下臉寬而方形1。中國國家藥品監督管理局 (NMPA) 最近批准了 BOTOX 化妝品，用於暫時增強成人顯著至極其顯著的 MMP 的外觀。 BOTOX Cosmetic 是中國第一個批准用於 MMP 的神經毒素，它包括規定的劑量、強大的臨床資料以及與標籤治療相關的醫生培訓。

與整形手術相關的副作用

與整形手術相關的副作用等因素預計將阻礙全球整形外科市場。感染、嚴重出血、疤痕、麻醉或植入相關的不良反應都是常見問題。這些危險不僅危及病人安全，還可能導致對結果不滿意，導致從業者承擔法律責任並損害其職業聲譽。例如，根據美國國立衛生研究院的數據，正在報告持續性肉芽腫和感染等長期不良事件。這些可能是由於無菌操作不嚴格或生物膜的形成造成的。填充劑的不良事件不僅可能持續存在，而且可能導致嚴重的併發症，例如永久性失明。

Plastic surgery is a surgical specialty involved with both the improvement of a person's appearance and the reconstruction of facial and body tissue defects due to illness, trauma, or birth disorders. Plastic surgery restores and improves function, as well as appearance. It can involve surgery on any part of the anatomy, except the central nervous system. A surgical specialty known as plastic surgery deals with the reconstruction, augmentation, or change of the human body. Cosmetic surgery and reconstructive surgery are the two subcategories of plastic surgery.

Moreover, rising consumer demand for these plastic procedures due to the increasing geriatric population, adoption of minimally invasive procedures, reduced procedural costs, an increase in the number of authorized service providers in the market, and an increase in the number of new product launches are driving up the plastic surgery market size. The market is experiencing a growth in demand for products from North American areas as a result of the development of research in these fields. Significant competitors like Allergan Aesthetics (AbbVie Inc.), Merz Aesthetics, Cynosure LLC, and others actively operating in the ma rket.

Market Dynamics: Drivers & Restraints

Increasing demand for plastic surgery procedures

The increasing demand for plastic surgery procedures is expected to be a significant factor in the growth of the global plastic surgery market. Factors such as the increasing geriatric population, increase in the number of scars and injuries, technological advancements, recent launches, and approvals increase the demand for plastic surgery procedures. The growing geriatric population is expected to have a substantial impact on the global plastic surgery market. As life expectancy increases and the older population grows, there is a greater need for aesthetic treatments that address age-related issues such as wrinkles, sagging skin, and volume loss. Facelifts, dermal fillers, and Botox injections are becoming increasingly popular among elderly individuals as a way to improve their appearance.

The rising occurrence of traffic accidents and burn injuries has resulted in a greater number of patients requiring scar therapy, driving up demand for various plastic surgery operations aimed at scar revision and aesthetic improvement. For instance, according to the World Health Organization, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year.

The number of procedures performed is increasing day by day due to the need for beautification and to improve appearance. For instance, according to the American Society of Plastic Surgeons, in 2023, in the US, a total of 304,181 Breast augmentation procedures, 347,782 liposuction procedures, and 120,747 eyelid surgeries and procedures were performed.

The increasing geriatric population is the major driver for market growth in the forecast period. As the geriatric population across the globe is rising, the demand for plastic surgery is increasing. For instance, as per the United Nations, in 2023, the global population above 60 years of age accounted for 1.06 billion, and the same age group population is expected to rise to 1.33 billion in 2030. For the increasing geriatric population, there are recent launches for plastic surgery and treatment. For instance, in September 2024, Allergan Aesthetics, an AbbVie company announced that BOTOX Cosmetic (onabotulinumtoxinA) is now available in China to treat masseter muscle predominance (MMP). The masseter muscle is one of the lower face's chewing muscles, and its predominance can result in a wide and square lower face shape1. The China National Medical Product Administration (NMPA) recently approved BOTOX Cosmetic to temporarily enhance the appearance of significant to extremely marked MMP in adults. BOTOX Cosmetic is the first neurotoxin approved in China for MMP, and it includes the defined dose, strong clinical data, and physician training associated with on-label treatment.

Side effects associated with plastic surgery

Factors such as side effects associated with plastic surgery are expected to hamper the global plastic surgery market. Infections, severe bleeding, scarring, and anesthetic or implant-related adverse responses are all common problems. These dangers not only endanger patient safety, but they can also lead to dissatisfaction with results, resulting in legal liability for practitioners and harming their professional reputations. For instance, according to the National Institute of Health, long-term adverse events such as persistent granulomas and infections are being reported. These may be due to laxity in aseptic procedures or the formation of biofilms. Adverse events with fillers can not only be persistent but can also lead to serious complications such as permanent blindness.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type gender, age group, end-user, and region.

The cosmetic (minimally-invasive) procedures segment is expected to dominate the global plastic surgery market share

The segment of minimally invasive cosmetic operations is expected to dominate the global plastic surgery market as a result of technical improvements, patient preferences, recent launches with technological advancements, and the inherent benefits of these procedures. Minimally invasive therapies, such as Botox injections, dermal fillers, and laser treatments, have grown in favor since they often require minimal incisions or none at all. This strategy lessens the physical damage associated with standard operations, as well as scars and recovery time, making these solutions more appealing to a broader audience.

Due to increasing demand for minimally invasive procedures, there are so many new launches, especially in the lasers section. For instance, in September 2023, Cutera, Inc. a global leader in aesthetic and dermatology solutions, announced the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. It is Optimized to treat varying layers of the skin; the Secret DUO is equipped with a radio frequency microneedling (RFMN) handpiece along with a fractional non-ablative 1540 nm erbium glass laser. The unique pairing of these modalities allows practitioners to provide fully customizable solutions for fine lines, texture, pigment, stretch marks, and scars.

Geographical Analysis

North America is expected to hold a significant position in the global plastic surgery market share

North America is expected to hold a significant portion of the global plastic surgery market. North America is anticipated to play a leading position in the global plastic surgery market owing to various factors such as the increasing geriatric population, technological advancements, recent launches and approvals, and the presence of strong players in this region. In this region, there is an increasing geriatric population which leads growth of the market in this region due to skin issues faced by the geriatric population. For instance, according to the Pew Research Center, the number of Americans ages 100 and older is projected to more than quadruple over the next three decades, from an estimated 101,000 in 2024 to about 422,000 in 2054, according to projections from the U.S. Census Bureau.

Due to the presence of the major players, there are recent launches and approvals in this region which makes this region hold a significant position in the global plastic surgery market. For instance, in January 2023, Reveal Lasers LLC announced the launch of the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The device's intuitive user interface has color-coded screens based on the active wavelength, allowing professionals to customize treatments for each patient. The strategic partnerships in this region are also one of the main reasons for the market to prosper in this region. For instance, in January 2024, United Aesthetics Alliance established to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, announced that it has formed a new partnership with the Bengtson Center for Aesthetics & Plastic Surgery. BCAPS, headquartered in Grand Rapids, MI, is a leading plastic surgery and aesthetics provider in West Michigan and it is led by two recognized board-certified plastic surgeons.

Asia Pacific is growing at the fastest pace in the global plastic surgery market

The Asia Pacific region is witnessing rapid expansion in the plastic surgery market, propelled by economic advancement, an increasing geriatric population, and technological advancements. This expansion is especially evident in nations such as Korea, Japan, and India, where investments in dermatology, skincare, and wellness, and awareness about plastic surgery procedures have been increasing day by day during recent times. There are recent approvals and launches in this region which propels the market. For instance, in May 2024, Korean startup MediThinQ announced the launch of its SCOPEYE 3D Micro Surgery Solution, which uses the latest Eyes Up Display technology for improving precision across medical specialties. The SCOPEYE 3D Micro Surgery Solution's portability and space-saving features make it suitable for a wide array of medical procedures, including microsurgery, dental procedures, plastic surgery, ophthalmology, hair transplant surgery, and dermatology.

Competitive Landscape

The major global players in the global plastic surgery market include Allergan Aesthetics (AbbVie Inc.), Alma Lasers, Cynosure LLC, Galderma, Bausch Health Companies Inc., Merz Aesthetics, Candela Corporation, Evolus, Inc., Lumenis Be Ltd., GC Aesthetics among others.

Emerging Players

MediThinQ, Avance Innovation, and ReConstruct Bio among others

Key Developments

In May 2023, the U.S. FDA approved SKINVIVE by JUVEDERM for enhancing the skin softness of the cheeks in individuals over the age of 21, according to a statement from Allergan Aesthetics, a division of AbbVie. The sole and first intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness to be made available in the United States is called SKINVIVE by JUVEDERM. With proper care, benefits can last up to six months. Smooth, injectable HA gel called SKINVIVE by JUVEDERM includes a trace dose of lidocaine, a local anesthetic.
In June 2023, Restylane Eyelight was approved by the U.S. Food and Drug Administration (FDA) for the treatment of dark shadows under the eyes in individuals over the age of 21. The first and sole product in the United States designed using NASHA Technology addressing volume loss beneath the eyes, Restylane Eyelight is a dermal filler made of hyaluronic acid (HA) that gives patients results that seem natural.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global plastic surgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Surgical Procedure Type
3.2. Snippet by Gender
3.3. Snippet by Age Group
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Geriatric Population
- 4.1.2. Restraints
  - 4.1.2.1. Side Effects Associated with Aesthetic Lasers
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Surgical Procedure Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 6.1.2. Market Attractiveness Index, By Surgical Procedure Type
6.2. Reconstructive Surgical Procedure*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cosmetic (aesthetic) Surgical Procedure
6.4. Cosmetic (Minimally-Invasive) Procedures

7. By Gender

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 7.1.2. Market Attractiveness Index, By Gender
7.2. Female*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Male

8. By Age Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. 13-19 yrs*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. 20-29 yrs
8.4. 30-39 yrs
8.5. 40-54 yrs
8.6. 55-69 yrs
8.7. 70+ yrs

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Surgical Centers/ Clinics
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Allergan Aesthetics (AbbVie Inc.)*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Alma Lasers
12.3. Cynosure LLC
12.4. Galderma
12.5. Bausch Health Companies Inc.
12.6. Merz Aesthetics
12.7. Candela Corporation
12.8. Evolus, Inc.
12.9. Lumenis Be Ltd.
12.10. GC Aesthetics.

LIST NOT EXHAUSTIVE